Idaho Country Free Press August 05, 2021, 06:49 am
Therapeutic Solutions International Receives FDA Clearance to Initiate Phase III Pivotal Registration Trial for JadiCell Universal Donor COVID-19 Therapy 1:49 PM
ELK CITY, Idaho, Aug. 5, 2021 /PRNewswire/ - Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today clearance from the Food and Drug Administration (FDA) to initiate a Phase III pivotal trial for registration of the Company's JadiCell universal donor...